Moscetti, L., Fabbri, M. A., Natoli, C., Vici, P., Gamucci, T., Sperduti, I., . . . Ruggeri, E. M. (2017). Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: The Ful500 prospective observational trial. Oncotarget.
शिकागो स्टाइल उद्धरणMoscetti, Luca, et al. "Fulvestrant 500 Milligrams As Endocrine Therapy for Endocrine Sensitive Advanced Breast Cancer Patients in the Real World: The Ful500 Prospective Observational Trial." Oncotarget 2017.
एमएलए उद्धरणMoscetti, Luca, et al. "Fulvestrant 500 Milligrams As Endocrine Therapy for Endocrine Sensitive Advanced Breast Cancer Patients in the Real World: The Ful500 Prospective Observational Trial." Oncotarget 2017.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.